rituximab

You have access
Bendamustine Plus Rituximab for Mantle Cell Lymphoma: A Korean, Multicenter Retrospective Analysis
JUN HO YI, SEOK JIN KIM, JEONG-OK LEE, GYEONG-WON LEE, JAE-YONG KWAK, HYEON-SEOK EOM, JAE-CHEOL JO, YOON SEOK CHOI, SUNG YONG OH and WON SEOG KIM

Anticancer Research December 2022, 42 (12) 6083-6089; DOI: https://doi.org/10.21873/anticanres.16120
You have access
The Economic Impact of Biosimilars in Oncology and Hematology: The Case of Trastuzumab and Rituximab
JACOPO GIULIANI and ANDREA BONETTI

Anticancer Research July 2019, 39 (7) 3971-3973; DOI: https://doi.org/10.21873/anticanres.13552
You have access
Comparable Efficacy of Idelalisib Plus Rituximab and Ibrutinib in Relapsed/refractory Chronic Lymphocytic Leukemia: A Retrospective Case Matched Study of the Polish Adult Leukemia Group (PALG)
BARTOSZ PUŁA, BOŻENA KATARZYNA BUDZISZEWSKA, JUSTYNA RYBKA, LIDIA GIL, EDYTA SUBOCZ, MONIKA DŁUGOSZ-DANECKA, DARIA ZAWIRSKA, ANNA WASZCZUK-GAJDA, ELŻBIETA ISKIERKA-JAŻDŻEWSKA, AGNIESZKA KOPACZ, AGNIESZKA SZYMCZYK, JAROSŁAW CZYŻ, EWA LECH-MARAŃDA, KRZYSZTOF WARZOCHA and KRZYSZTOF JAMROZIAK

Anticancer Research May 2018, 38 (5) 3025-3030;
You have access
Multi-Database Description of Primary Splenic Diffuse Large B-Cell Lymphoma
KENNETH P. BYRD, NAMRATHA R. VONTELA, BRENNAN MCCULLAR and MIKE G. MARTIN

Anticancer Research December 2017, 37 (12) 6839-6843;
You have access
Bendamustin–Rituximab Combination Is a Safe and Effective, Ambulatory Treatment for Elderly Patients with Chronic Lymphocytic Leukemia: Retrospective Real-world Analysis by Age from a German Registry and Review of the Literature
ULRICH RICHARD KLEEBERG, HARTMUT LINDE, GEORG GÜNTHER, HANS-WERNER TESSEN and MARKUS KERSTING

Anticancer Research June 2016, 36 (6) 2827-2838;
You have access
Chronic Lymphocytic Leukemia: Current Concepts
EUN-MI YU, ADAM KITTAI and IMAD A. TABBARA

Anticancer Research October 2015, 35 (10) 5149-5165;
You have access
Routine Use of Bendamustine in Patients with Chronic Lymphocytic Leukemia: An Observational Study
MARIJANA NINKOVIC, MICHAEL FIEGL, MICHAEL MIAN, PATRIZIA MONDELLO, FLORIAN KOCHER, CHRISTIAN WALDTHALER, IRMGARD VERDORFER, MICHAEL STEURER, GÜNTHER GASTL and ANDREAS PIRCHER

Anticancer Research September 2015, 35 (9) 5129-5139;
You have access
Risk of Second Primary Cancer in Patients with B-cell Non-Hodgkin Lymphoma Receiving Rituximab-containing Chemotherapy: A Nationwide Population-based Study
SHIH-FENG CHO, WAN-HSUAN WU, YI-HSIN YANG and CHAO-SUNG CHANG

Anticancer Research March 2015, 35 (3) 1809-1814;
You have access
Radiotherapy for Stage I/II Follicular Lymphoma (FL): Is it Time for A Re-appraisal?
PATRIZIA MONDELLO, NORMANN STEINER, INES WASLE, VINCENZO PITINI and MICHAEL MIAN

Anticancer Research November 2014, 34 (11) 6701-6704;
You have access
Survival in Advanced Diffuse Large B-Cell Lymphoma in Pre- and Post-rituximab Eras in the United States
BINAY KUMAR SHAH, AMIR BISTA and BAHMAN SHAFII

Anticancer Research September 2014, 34 (9) 5117-5120;

Main menu

User menu

Search

rituximab

Pages